Endocyte Inc. diskutieren
Endocyte Inc.
WKN: A1H68U / Symbol: ECYT / Name: Endocyte / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
Gesundheit | Biotechnologie | Vereinigte Staaten
Biotechnologie und medizinische SecteurRecherche
$ ECYT mit einem Outperform bei Wells Fargo initiiert. $ 20 PT
Endocyte is working on developing therapy to combat tumors
The company is also focused on developing promising companion agents for identifying patients most likely to benefit from its targeted therapy.
Endocyte is preparing to enter its adaptor-controlled CAR-T program in clinic in Q4 2018.
Lutetium-PSMA-617 is a promising radioligand therapy targeting advanced prostate cancer.
Neueste Beiträge
WatchMen in Taseko Mines Ltd diskutieren